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What is Low Dose Computed 
Tomography (LDCT)?
• Patients who have a high chance of lung cancer 
may undergo a LDCT scan. 
• LDCT uses a unique CT scan protocol that 
produces images of sufficient quality to detect 
many abnormalities while using up to 90% less 
ionizing radiation than a standard Chest CT 
(RadiologyInfo.org, n.d.). 
• National Comprehensive Cancer Network 
(NCCN) suggest the use of LDCT screenings 
for early lung cancer detection (Gjermundson & 
Clark, 2019). 
• To be considered low dose, the effective dose 
for CT must be 1.5 millisieverts (mSv), 
compared to 7 mSv for a regular chest CT (Rulli
& Matthews, 2020). 
• The effective dose is defined as overall long-
term risk of radiation exposure from 
examinations or procedures (Rulli & Matthews, 
2020).
• LDCT scans is the preferred technology of 
choice to detect lung cancer early. 
• LDCT scans can visualize small tumors that are 
unseen on traditional chest x-rays (Rulli & 
Matthews, 2020). 
• LDCT has a higher sensitivity and specificity 
for early lung cancer detection than chest 
radiography and sputum cytology (Rulli & 
Matthews, 2020).
• Chest CT scans can detect nodules less than 1 
cm in diameter (Komaki, Roth, & Ki Hong, 2014). 
Patient Demographics
In order to qualify for a LDCT, the patient must 
meet the following criteria:
• Age- must be 55 to 80 years old (Gjermundson & 
Clark, 2019).
• Male/Female- Males are more likely to smoke 
(Rulli & Matthews, 2020).
• Ethnicity- All ethnicities are eligible, however 
African American men are more likely to die 
from lung cancer (Rulli & Matthews, 2020). 
• Smoking History- Patients who have a 30 pack-
year smoking history, currently smoke or have 
quit within the past 15 years (Gjermundson & Clark, 
2019). 
It is important to target high risk populations such 
as sexual minorities. Sexual minorities, who identify 
as lesbian, gay, bisexual, transgender (LBGT) are at 
a greater risk of smoking and tobacco use disorders 
than heterosexuals (Veliz et al., 2019). The odds of 
LBGT community indicating eligibility for LDCT 
screenings were higher than heterosexuals. 
Smoking Cessation
Smoking Cessation programs are highly effective 
and reduce the lung cancer risk. An analysis of 
historical data that compared the benefits of 
smoking cessation and lung cancer screening found 
that smoking cessation would have resulted in 
reduced mortality more than 2 times that of LDCT 
screenings (Gjermundson & Clark, 2019). 
Smoking cessation can improve pulmonary function 
and circulation within 2 weeks to 3 months after 
quitting (Komaki, Roth, & Ki Hong, 2014). 1-9 months 
the ciliary function of the lung epithelium is 
restored; might experience increased coughing as 
lungs clear mucus (Komaki, Roth, & Ki Hong, 2014). 
After 5-15 years the risk of a stroke is reduced; 
chance of dying of lung cancer is approximately 
half that of continuing smokers (Komaki, Roth, & Ki 
Hong, 2014). 
Benefit
The National Cancer Institute confirmed LDCT can 
detect lung cancer early in some patients. When 
detected early it increases the chance of survival and 
treatment options for patients with lung cancer 
(Rulli, & Matthews, 2020). 
Introduction
Lung cancer is the second most common form of 
cancer in the United States. Smoking is the 
primary cause of lung cancer, accounting for 
85%-90% of all lung cancer deaths (Rulli & 
Matthews, 2020). There are two types of lung cancer:
• Non small cell lung cancer (NSCLC)
• Adenocarcinoma- occurs in current or 
former smokers; found in outer portion of 
the lungs.
• Squamous cell carcinoma- caused by history 
of smoking; found in central part of lungs 
by airway. 
• Large cell carcinoma- can grow and spread 
rapidly; found in any portion of the lung. 
•Small cell lung cancer (SCLC). 
• About 10% to 15 of all lung cancers are 
SCLC (American Cancer Society, n.d.).
• Grows and spreads faster than NSCLC.
Computed Tomography
• Computed tomography (CT) is a noninvasive 
imaging test.
• Creates cross sectional images of organs, bones, 
soft tissue and blood vessels. 
• The images generated during a CT scan can be 
reformatted in multiple planes and generates 
three dimensional images (RadiologyInfo.org, n.d.). 
• CT scans are often preferred as it can detect many 
types of cancers. 
Risks
A major concern regarding Lung Cancer Screenings 
is the associated risk for radiation-induced cancer 
(Perisinakis et al., 2018). Patient radiation burden from 
LDCT scans of the chest has been reported in 
several studies in terms of effective dose derived 
through the dose length product (Perisinakis et al., 
2018). LDCT is estimated to have an effective 
radiation dose of approximately 1.5 mSv per annual 
exam, whereas a diagnostic chest CT has an 
effective dose of 8 mSv (Komaki, Roth, & Ki Hong, 
2014). 
False positives are possible resulting in unnecessary 
tests for the patient. Additional testing can increase 
radiation dose and financial cost. Approximately 
75% of the scans in the NLST trial were normal, the 
false-positive rate was about 24% (Gjermudson & 
Clark, 2019).
Non- calcified nodules (NCNs) can be discovered 
with false positive LDCT screenings for lung cancer 
have been attributed to various cases, including 
infectious and inflammatory processes (Pinski & 
Gierada, 2020). NCNs may indicate a precursor for 
lung cancer
Incidental findings can occur when LDCT scans are 
performed. This can lead to further testing, 73% of 
the NELSON trial suggested 1 nonclinical relevant 
incidental finding, such as pulmonary fibrosis, 
emphysema, and enlarged lymph nodes (Gjermudson
& Clark, 2019).
Conclusion 
LDCT scans are important for patients who are at 
high-risk for lung cancer. Studies have indicated 
LDCT scans can detect lung cancer early, which can 
impact the survival rate. To be considered for a 
LDCT scan patients meet specific requirements 
such as age and smoking history. 
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Black arrow indicating squamous cell 
carcinoma of the right lung. (Dayo, 2018).
CT scans shows spiculated nodule in 
right upper lobe. (Radiology Key, 2016). 
Non-small cell lung carcinoma in upper 
lobe of left lung. (Heilman, 2017). 
